Publications
HIV-specific and resistant CAR T cells promote control of HIV replication in people with HIV
Res Sq [Preprint]. | 2026 Jul
MVA.HIVconsvX vaccination-evoked T cell expansion inversely associates with age in people with HIV-1 on antiretroviral therapy
J Clin Invest. | 2026 May
Expansion of stemlike HIV-specific CD8(+) T cells and limited viral epitope diversity characterize durable posttreatment control of HIV
Sci Transl Med. | 2026 Apr
Allograft Rejection and the Latent HIV Reservoir in Kidney Transplant Recipients with HIV
J Infect Dis. | 2026 Mar
Interleukin-2 is a potent latency reversal agent in people with treated HIV-1
Sci Adv. | 2025 Dec
Comparison of manual and automated ultrasensitive assays for residual HIV-1 in plasma from individuals on suppressive antiretroviral therapy
J Clin Microbiol. | 2025 Dec
Retinol Binding Protein 4 reactivates latent HIV-1 by triggering canonical NF-κB, JAK/STAT5 and JNK signalling
Signal Transduct Target Ther. | 2025 Oct
Intact and Defective HIV Provirus Changes During Antiretroviral Therapy in People Treated During Acute or Chronic HIV Infection or as HIV Controllers
Open Forum Infect Dis. | 2025 Sep
BCL-2 Inhibition via Venetoclax at ART Initiation Induces Long-Term Reduction of the Intact SIV Reservoir
Res Sq [Preprint]. | 2025 Jul
Single-cell analyses identify monocyte gene expression profiles that influence HIV-1 reservoir size in acutely treated cohorts
Nat Commun. | 2025 May
Ex vivo and in vivo HIV-1 latency reversal by “Mukungulu,” a protein kinase C-activating African medicinal plant extract
mBio. | 2025 May
A First-in-Class Dual Degrader of Bcl-2/Bcl-xL Reverses HIV Latency and Minimizes Ex Vivo Reservoirs from Patients
Int J Mol Sci. | 2025 Mar
Galectin 9 Levels as a Potential Predictor of Intact HIV Reservoir Decay
J Infect Dis. | 2025 Feb
SIV Env RhmAbs + N-803 at ART initiation prolongs viral decay without disrupting reservoir establishment in SIV-infected infant macaques
PLoS Pathog. | 2025 Jan
Single-cell analyses reveal that monocyte gene expression profiles influence HIV-1 reservoir size in acutely treated cohorts
bioRxiv[Preprint] | 2024 Nov
Rapid biphasic decay of intact and defective HIV DNA reservoir during acute treated HIV disease
Nat Commun. | 2024 Nov
The immunogenicity of an HIV-1 Gag conserved element DNA vaccine in people with HIV and receiving antiretroviral therapy
AIDS | 2024 Jun
HIV-1 Remission after Allogeneic Hematopoietic-Cell Transplantation
N Engl J Med. | 2024 Feb
HIV-Positive Liver Transplant Does not Alter the Latent Viral Reservoir in Recipients With Antiretroviral Therapy-Suppressed HIV
J Infect Dis. | 2023 Nov
The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy
J Clin Invest. | 2023 Sep
Current HIV/SIV Reservoir Assays for Preclinical and Clinical Applications: Recommendations from the Experts 2022 NIAID Workshop Summary
AIDS Res Hum Retroviruses | 2023 Jun
Varied Patterns of Decay of Intact Human Immunodeficiency Virus Type 1 Proviruses Over 2 Decades of Antiretroviral Therapy
J Infect Dis. | 2023 Jun
The effect of induction immunosuppression for kidney transplant on the latent HIV reservoir
JCI Insight | 2022 Nov
Measuring the latent reservoir for HIV-1: Quantification bias in near full-length genome sequencing methods
PLoS Pathog | 2022 Sep
Evaluation of HIV-1 reservoir size and broadly neutralizing antibody susceptibility in acute antiretroviral therapy-treated individuals
AIDS | 2022 Feb
Single center, open label dose escalating trial evaluating once weekly oral ixazomib in ART-suppressed, HIV positive adults and effects on HIV reservoir size in vivo
EClinical Medicine | 2021 Nov
The TLR7 agonist vesatolimod induced a modest delay in viral rebound in HIV controllers after cessation of antiretroviral therapy
Sci Transl Med. | 2021 Jun
Similar Frequency and Inducibility of Intact Human Immunodeficiency Virus-1 Proviruses in Blood and Lymph Nodes
J Infect Dis. | 2021 Jul
Vesatolimod, a Toll-like Receptor 7 Agonist, Induces Immune Activation in Virally Suppressed Adults Living With Human Immunodeficiency Virus-1
Clin Infect Dis. | 2021 Jun
Nonstructured Treatment Interruptions Are Associated With Higher Human Immunodeficiency Virus Reservoir Size Measured by Intact Proviral DNA Assay in People Who Inject Drugs
J Infect Dis. | 2021 Jun
Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy
J Infect Dis. | 2021 Feb
Intact Human Immunodeficiency Virus (HIV) Reservoir Estimated by the Intact Proviral DNA Assay Correlates With Levels of Total and Integrated DNA in the Blood During Suppressive Antiretroviral Therapy
Clin Infect Dis. | 2021 Feb
Shared Mechanisms Govern HIV Transcriptional Suppression in Circulating CD103(+) and Gut CD4(+) T Cells
J Virol | 2020 Dec
Distinct viral reservoirs in individuals with spontaneous control of HIV-1
Nature | 2020 Sep
Intact proviral DNA assay analysis of large cohorts of people with HIV provides a benchmark for the frequency and composition of persistent proviral DNA
Proc Natl Acad Sci U S A | 2020 Aug
Elite suppressors have low frequencies of intact HIV-1 proviral DNA
AIDS | 2020 Mar
Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapy
JCI Insight | 2020 Feb
The Landscape of Persistent Viral Genomes in ART-Treated SIV, SHIV, and HIV-2 Infections
Cell Host Microbe | 2019 Jul
A quantitative approach for measuring the reservoir of latent HIV-1 proviruses
Nature | 2019 Feb